Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive tranexamic acid for hemorrhage control during myomectomy
PACTR202607470597411Phase 3Completed
- Sponsor
- Wasiu Onasanya
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tranexamic acid in Fibromyoma (LM) (2 arms), sponsored by Wasiu Onasanya. Primary endpoint: Intraoperative estimated blood loss. Started Jun 2021; status: completed.
02
Drugs
tranexamic acid
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on PACTR202607470597411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202607470597411.